222110 Stock Chart & Stats
₩4780.00
-₩120.00(-2.45%)
―
--
Day’s Range― - ―
52-Week Range₩4,220.00 - ₩8,510.00
Previous CloseN/A
VolumeN/A
Average Volume (3M)15.06K
Market Cap
₩64.87B
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)31.7
Beta0.15
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding13,514,509
10 Day Avg. Volume12,020
30 Day Avg. Volume15,056
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
222110 FAQ
What was PanGen Biotech, Inc.’s price range in the past 12 months?
PanGen Biotech, Inc. lowest stock price was ₩4220.00 and its highest was ₩8510.00 in the past 12 months.
What is PanGen Biotech, Inc.’s market cap?
PanGen Biotech, Inc.’s market cap is ₩64.87B.
When is PanGen Biotech, Inc.’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were PanGen Biotech, Inc.’s earnings last quarter?
PanGen Biotech, Inc. released its earnings results on May 14, 2026. The company reported ₩55.623 earnings per share for the quarter, beating the consensus estimate of N/A by ₩55.623.
Is PanGen Biotech, Inc. overvalued?
According to Wall Street analysts PanGen Biotech, Inc.’s price is currently Undervalued.
Does PanGen Biotech, Inc. pay dividends?
PanGen Biotech, Inc. does not currently pay dividends.
What is PanGen Biotech, Inc.’s EPS estimate?
PanGen Biotech, Inc.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does PanGen Biotech, Inc. have?
PanGen Biotech, Inc. has 13,514,509 shares outstanding.
What happened to PanGen Biotech, Inc.’s price movement after its last earnings report?
PanGen Biotech, Inc. reported an EPS of ₩55.623 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went up 0.982%.
Which hedge fund is a major shareholder of PanGen Biotech, Inc.?
Currently, no hedge funds are holding shares in KR:222110
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
ORIENTBIO, Inc.
―
Eone Diagnomics Genome Center Co., Ltd.
―
SCL Science Inc.
―
PROTIA INC.
―
KoBioLabs, Inc.
―